Construction of CDKN2A-related competitive endogenous RNA network and identification of GAS5 as a prognostic indicator for hepatocellular carcinoma

Figure 6 Construction and validation of the competitive endogenous RNA regulatory network. A: The model of the competitive endogenous RNA axis in the progression of hepatocellular carcinoma (HCC); B: The expression of growth arrest-specific 5 was significantly upregulated in HCC; C: the expression of SRY-box transcription factor 11 (SOX11) was significantly upregulated in HCC; D: Kaplan-Meier curves of SOX11 in patients with HCC in the low and high expression groups; E: Correlation analysis between SOX11 and cyclin dependent kinase inhibitor 2A in HCC. HCC: Hepatocellular carcinoma; CDKN2A: Cyclin dependent kinase inhibitor 2A; GAS5: Growth arrest-specific 5; SOX11: SRY-box transcription factor 11.